Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
A new common mechanism in Fragile X and Down syndrome has been identified by scientists at Ulsan National Institute of Science and Technology (UNIST), Korea and published in the world leading science journal, Trends in Neurosciences (Cell Press).
Title : Meeting at the crossroads: Common mechanisms in Fragile X and Down syndrome*
Emerging evidence shows that the regulation of local protein synthesis in dendritic spines plays a crucial role in controlling synaptic morphogenesis and synaptic efficacy. However, scientist do not yet understand how local protein synthesis regulates dendritic spine morphology, a process that is important for learning and memory.
The research team led by Prof. Kyung-Tai Min from UNIST presented evidence that pathways controlled by DSCR1 and FMRP, genes implicated in two of the most common genetic causes of intellectual disabilities - DS and FXS converge to regulate spine morphogenesis, local protein synthesis, and neurotransmission.
Min's research team highlighted the *previous research work published in The EMBO Journal by Prof. Min, showing that some of the proteins altered in Fragile X and Down syndrome are common molecular triggers of intellectual disability in both disorders, DS and FXS.
Title: DSCR1 interacts with FMRP and is required for spine morphogenesis and local protein synthesis**
They reviewed other genes encoded by chromosome 21 that may regulate dendritic spine morphogenesis and contribute to intellectual disabilities by acting through pathways involving FMRP and DSCR1.
The research work provided an important stepping stone in understanding the multiple roles of DSCR1 in neurons and in identifying a molecule that is closely linked to intellectual disability for both syndromes.
"We will continuously investigate whether reducing FMRP in DS mouse model or elevating DSCR1 in FMRP knockout mice could restore synaptic plasticity, dendritic spine morphogenesis, and local protein synthesis will further advance our understanding of both diseases," said Prof. Min, presenting future research plan.
"Further elucidation of the large functional protein-inter-action network that regulates local protein synthesis, spine morphogenesis, and synaptic transmission may also shed light on overlapping molecular pathways that cause intellectual disabilities in different disorders," added Prof. Min.
This research work was supported by grants from Ulsan National Institute of Science and Technology, the Korea Ministry of Education, Science and Technology and Foundation Jerome Lejeune.
*Meeting at the crossroads: common mechanisms in Fragile X and Down syndrome Karen T. Chang, Hyunah Ro, Wei Wang, Kyung-Tai Min, Trends in Neurosciences doi: 10.1016/j.tins.2013.08.007 26 September 2013
**Title: DSCR1 interacts with FMRP and is required for spine morphogenesis and local protein synthesis Wei Wang, John Z Zhu, Karen T Chang and Kyung-Tai Min, The EMBO Journal (2012) 31, 3655 - 3666 doi:10.1038/emboj.2012.190 Published online: 3 August 2012
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Genetics category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Ulsan National Institute of Science and Technology. "Common mechanisms in fragile x and down syndrome: new theory in neuroscience." Medical News Today. MediLexicon, Intl., 3 Oct. 2013. Web.
9 Dec. 2013. <http://www.medicalnewstoday.com/releases/266881>
Ulsan National Institute of Science and Technology. (2013, October 3). "Common mechanisms in fragile x and down syndrome: new theory in neuroscience." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/266881.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.